Prostate Cancer

2 medicines

Prostate cancer is one of the most common cancers in men, usually growing slowly and caught early through PSA blood tests. Advanced disease is managed by lowering androgen activity with medicines such as flutamide and abiraterone.

Abiraterone Tablets

Abiraterone

250mg

Abiraterone Tablets is a oncology medication containing Abiraterone, available as 250mg tablets.

from $3.15 / tablet View

Eulexin

Flutamide

250mg

Eulexin is a oncology medication containing Flutamide, available as 250mg tablets.

from $2.02 / tablet View

Key facts

  • Prostate cancer is one of the most common cancers affecting men. Most cases grow slowly and are found on a routine PSA blood test before symptoms develop.
  • Advanced disease can cause urinary difficulty, pelvic discomfort, or bone pain.
  • Prostate cancer cells typically rely on androgens (male hormones) to grow, so lowering androgen activity is central to treating advanced or metastatic disease.
  • Flutamide and abiraterone are two of the anti-androgen medicines used, alongside surgery, radiotherapy, or active monitoring depending on stage.

How prostate cancer develops

The prostate is a small gland that sits below the bladder, and cancer here often grows slowly over years. Because early prostate cancer rarely causes symptoms, it's frequently detected through a routine PSA (prostate-specific antigen) blood test rather than because of how someone feels. When symptoms do appear, especially in more advanced disease, they can include urinary difficulty, pelvic discomfort, or bone pain if the cancer has spread.

Hormone-based treatment

Prostate cancer cells typically depend on androgens to grow, so reducing androgen activity is the cornerstone of treatment for advanced or metastatic disease. Flutamide is an anti-androgen that blocks testosterone from reaching cancer cells and has been used for decades. Abiraterone works further upstream, blocking the body's production of androgens, including in the adrenal glands and the tumour itself, and is often used when cancer progresses despite initial hormone therapy. Both belong to the wider range of treatments found in oncology care.

When to see a doctor

Men diagnosed with prostate cancer should have their treatment plan reviewed by an oncologist or urologist, since the right approach depends heavily on the cancer's stage, grade, and the person's overall health. Anyone with new urinary symptoms, unexplained pelvic pain, or a family history of prostate cancer should also discuss PSA screening with a doctor.

This page is educational and does not replace advice from a doctor or pharmacist who knows your health history.